A common E2F-1 and p73 pathway mediates cell death induced by TCR activation

被引:287
作者
Lissy, NA
Davis, PK
Irwin, M
Kaelin, WG
Dowdy, SF [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1038/35036608
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Strong stimulation of the T-cell receptor (TCR) on cycling peripheral T cells causes their apoptosis by a process called TCR-activation-induced cell death (TCR-AICD)(1-3). TCR-AICD occurs from a late G1 phase cell-cycle check point(4) independently of the 'tumour suppressor' protein p53 (refs 5, 6). Disruption of the gene for the E2F-1 transcription factor(7,8), an inducer of apoptosis(9-11), causes significant increases in T-cell number and splenomegaly(12-15). Here we show that T cells undergoing TCR-AICD induce the p53-related gene p73, another mediator of apoptosis(16), which is hypermethylated in lymphomas(17,18). Introducing a dominant-negative E2F-1 protein or a dominant-negative p73 protein into T cells protects them from TCR-mediated apoptosis, whereas dominant-negative E2F-2, E2F-4 or p53 does not. Furthermore, E2F-1-null or p73-null primary T cells do not undergo TCR-mediated apoptosis either. We conclude that TCR-AICD occurs from a late G1 cell-cycle checkpoint that is dependent on both E2F-1 and p73 activities. These observations indicate that, unlike p53, p73 serves to integrate receptor-mediated apoptotic stimuli.
引用
收藏
页码:642 / 645
页数:5
相关论文
共 30 条
[1]  
ABRAMS SI, 1991, J IMMUNOL, V146, P405
[2]  
Boehme SA, 1996, J IMMUNOL, V156, P4075
[3]  
Corn PG, 1999, CANCER RES, V59, P3352
[4]   Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome [J].
Davison, TS ;
Yin, P ;
Nie, E ;
Kay, C ;
Arrowsmith, CH .
ONCOGENE, 1998, 17 (05) :651-656
[5]   Additional complexity in p73:: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ [J].
De Laurenzi, V ;
Catani, MV ;
Terrinoni, A ;
Corazzari, M ;
Melino, G ;
Costanzo, A ;
Levrero, M ;
Knight, RA .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :389-390
[6]   Distinct roles for E2F proteins in cell growth control and apoptosis [J].
DeGregori, J ;
Leone, G ;
Miron, A ;
Jakoi, L ;
Nevins, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7245-7250
[7]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[8]   The regulation of E2F by pRB-family proteins [J].
Dyson, N .
GENES & DEVELOPMENT, 1998, 12 (15) :2245-2262
[9]   E2F-1 functions in mice to promote apoptosis and suppress proliferation [J].
Field, SJ ;
Tsai, FY ;
Kuo, F ;
Zubiaga, AM ;
Kaelin, WG ;
Livingston, DM ;
Orkin, SH ;
Greenberg, ME .
CELL, 1996, 85 (04) :549-561
[10]  
García I, 2000, CELL GROWTH DIFFER, V11, P91